Long‐Term Effectiveness of Once‐Weekly Semaglutide in Patients With Type 2 Diabetes Previously Treated With Insulin. A Multicentre Real‐World Study
Our study highlights OW semaglutide as a valuable addition to a T2D regimen based on insulin, offering effective glycaemic and weight control with the potential for insulin deintensification or discontinuation.
Authors
- Agostino Consoli (ORCID: https://orcid.org/0000-0002-1885-451X)
- Gian Paolo Fadini (ORCID: https://orcid.org/0000-0002-6510-2097)
- Angelo Avogaro (ORCID: https://orcid.org/0000-0002-1177-0516)
- Fabio Broglio (ORCID: https://orcid.org/0000-0002-1747-6094)
- Benedetta Maria Bonora (ORCID: https://orcid.org/0000-0002-6770-2723)
- Andrea Giaccari (ORCID: https://orcid.org/0000-0002-7462-7792)
Institutions
- Università Cattolica del Sacro Cuore (IT)
- University of Padua (IT)
- University of Chieti-Pescara (IT)
- Veneto Institute of Molecular Medicine (IT)
- Azienda USL di Pescara (IT)
- University of Turin (IT)
Publication Details
- Journal
- Diabetes/Metabolism Research and Reviews
- Published
- 2025-04-25
- DOI
- https://doi.org/10.1002/dmrr.70045
- Citations
- 1
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 1.29